These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement. Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844 [TBL] [Abstract][Full Text] [Related]
12. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management. Megaly M; Garcia S; Anzia LE; Morley P; Garberich R; Gornick CC; Lesser J; Sorajja P; Gössl M; Sengupta J J Invasive Cardiol; 2019 Jul; 31(7):E177-E183. PubMed ID: 31257211 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiological consequences of the EAST-AFNET4 trial: AF is not an innocent bystander. Goette A Cardiovasc Res; 2020 Dec; 116(14):e200-e201. PubMed ID: 33205206 [No Abstract] [Full Text] [Related]
14. Anticoagulation With or Without Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement for Patients With Atrial Fibrillation: A Meta-Analysis. Yokoyama Y; Briasoulis A; Takagi H; Kuno T Cardiovasc Revasc Med; 2021 Mar; 24():42-47. PubMed ID: 32830088 [TBL] [Abstract][Full Text] [Related]
15. Revisiting Atrial Fibrillation in the Transcatheter Aortic Valve Replacement Era. Parikh K; Dizon J; Biviano A Interv Cardiol Clin; 2018 Oct; 7(4):459-469. PubMed ID: 30274612 [TBL] [Abstract][Full Text] [Related]
16. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management. Sherwood MW; Vora AN Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013 [TBL] [Abstract][Full Text] [Related]
17. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement. Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936 [TBL] [Abstract][Full Text] [Related]
18. New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Ryan T; Grindal A; Jinah R; Um KJ; Vadakken ME; Pandey A; Jaffer IH; Healey JS; Belley-Coté ÉP; McIntyre WF JACC Cardiovasc Interv; 2022 Mar; 15(6):603-613. PubMed ID: 35331452 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Tarantini G; Mojoli M; Urena M; Vahanian A Eur Heart J; 2017 May; 38(17):1285-1293. PubMed ID: 27744287 [TBL] [Abstract][Full Text] [Related]
20. New concepts in the therapy of atrial fibrillation. Cocco G; Jerie P Cardiol J; 2016; 23(1):3-11. PubMed ID: 26412599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]